BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 37009688)

  • 1.
    Little A; Tangney M; Tunney MM; Buckley NE
    Expert Rev Mol Med; 2023 Apr; 25():e15. PubMed ID: 37009688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
    mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances on the treatment of
    Wang H; Hou X; Liu J; Yang C
    Sheng Wu Gong Cheng Xue Bao; 2023 Sep; 39(9):3670-3680. PubMed ID: 37805845
    [No Abstract]   [Full Text] [Related]  

  • 4.
    Martin-Gallausiaux C; Salesse L; Garcia-Weber D; Marinelli L; Beguet-Crespel F; Brochard V; Le Gléau C; Jamet A; Doré J; Blottière HM; Arrieumerlou C; Lapaque N
    Gut Microbes; 2024; 16(1):2295384. PubMed ID: 38126163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusobacterium nucleatum and T Cells in Colorectal Carcinoma.
    Mima K; Sukawa Y; Nishihara R; Qian ZR; Yamauchi M; Inamura K; Kim SA; Masuda A; Nowak JA; Nosho K; Kostic AD; Giannakis M; Watanabe H; Bullman S; Milner DA; Harris CC; Giovannucci E; Garraway LA; Freeman GJ; Dranoff G; Chan AT; Garrett WS; Huttenhower C; Fuchs CS; Ogino S
    JAMA Oncol; 2015 Aug; 1(5):653-61. PubMed ID: 26181352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ways Fusobacterium nucleatum translocate to breast tissue and contribute to breast cancer development.
    Guo X; Yu K; Huang R
    Mol Oral Microbiol; 2024 Feb; 39(1):1-11. PubMed ID: 38171827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The onco-immunological implications of Fusobacterium nucleatum in breast cancer.
    Van der Merwe M; Van Niekerk G; Botha A; Engelbrecht AM
    Immunol Lett; 2021 Apr; 232():60-66. PubMed ID: 33647328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer.
    Haruki K; Kosumi K; Hamada T; Twombly TS; Väyrynen JP; Kim SA; Masugi Y; Qian ZR; Mima K; Baba Y; da Silva A; Borowsky J; Arima K; Fujiyoshi K; Lau MC; Li P; Guo C; Chen Y; Song M; Nowak JA; Nishihara R; Yanaga K; Zhang X; Wu K; Bullman S; Garrett WS; Huttenhower C; Meyerhardt JA; Giannakis M; Chan AT; Fuchs CS; Ogino S
    J Pathol; 2020 Apr; 250(4):397-408. PubMed ID: 31880318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
    World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ye X; Wang R; Bhattacharya R; Boulbes DR; Fan F; Xia L; Adoni H; Ajami NJ; Wong MC; Smith DP; Petrosino JF; Venable S; Qiao W; Baladandayuthapani V; Maru D; Ellis LM
    Cancer Prev Res (Phila); 2017 Jul; 10(7):398-409. PubMed ID: 28483840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum carcinogenesis and drug delivery interventions.
    Chen Z; Huang L
    Adv Drug Deliv Rev; 2024 Jun; 209():115319. PubMed ID: 38643839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer colonization by Fusobacterium nucleatum accelerates tumor growth and metastatic progression.
    Parhi L; Alon-Maimon T; Sol A; Nejman D; Shhadeh A; Fainsod-Levi T; Yajuk O; Isaacson B; Abed J; Maalouf N; Nissan A; Sandbank J; Yehuda-Shnaidman E; Ponath F; Vogel J; Mandelboim O; Granot Z; Straussman R; Bachrach G
    Nat Commun; 2020 Jun; 11(1):3259. PubMed ID: 32591509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
    Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
    Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fusobacterium nucleatum detected simultaneously in a pyogenic liver abscess and advanced sigmoid colon cancer.
    Shigefuku R; Watanabe T; Kanno Y; Ikeda H; Nakano H; Hattori N; Matsunaga K; Matsumoto N; Kanno SI; Nosho K; Hachiya A; Iwatani Y; Matsumori T; Tsukikawa S; Makizumi R; Otsubo T; Yamamoto H; Itoh F
    Anaerobe; 2017 Dec; 48():144-146. PubMed ID: 28823592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
    Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
    Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis.
    Hayashi M; Ikenaga N; Nakata K; Luo H; Zhong P; Date S; Oyama K; Higashijima N; Kubo A; Iwamoto C; Torata N; Abe T; Yamada Y; Ohuchida K; Oda Y; Nakamura M
    Cancer Sci; 2023 Sep; 114(9):3666-3678. PubMed ID: 37438965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of severe Fusobacterium nucleatum sepsis secondary to nephrectomy.
    Liu C; Jia Q; Wang L; Yang D
    BMC Infect Dis; 2022 Mar; 22(1):309. PubMed ID: 35351006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut.
    Bashir A; Miskeen AY; Hazari YM; Asrafuzzaman S; Fazili KM
    Tumour Biol; 2016 Mar; 37(3):2805-10. PubMed ID: 26718210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.
    Jiang SS; Xie YL; Xiao XY; Kang ZR; Lin XL; Zhang L; Li CS; Qian Y; Xu PP; Leng XX; Wang LW; Tu SP; Zhong M; Zhao G; Chen JX; Wang Z; Liu Q; Hong J; Chen HY; Chen YX; Fang JY
    Cell Host Microbe; 2023 May; 31(5):781-797.e9. PubMed ID: 37130518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.